Keywords: USA, Drug recalls, Warning letters, FDA, GBI

Increase in US drug recalls and warning caused by manufacturing errors and regulatory non-compliance issues, says GBI

Article | 15 November 2011

The numbers of warning letters and drug recalls issued by and reported to the US Food and Drug Administration (FDA) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in